U.S. Market Projected to Hit USD 7.06 Billion by 2035 While Europe Market Expected to Reach USD 6.42 Billion as Aging Male Population Fuels Demand for Advanced BPH Therapies.Austin, United States, May ...
2d
JW Pharmaceutical and JW Shinyak Hold Symposium on Benign Prostatic Hyperplasia Treatment "Truepass"
JW Pharmaceutical and JW Shinyak announced on the 10th that they held the "J STAR Symposium" at the Grand Walkerhill Seoul ...
Both robot-assisted simple prostatectomy (RASP) and laser enucleation of the prostate (LEP) are safe and effective surgical options for large-volume benign prostatic hyperplasia (BPH), according to a ...
The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...
Prostate health is vital for men over fifty as conditions like BPH, prostatitis, and cancer can affect urinary function and ...
The Society of Interventional Radiology (SIR) published a new practice guidance on prostate artery embolization (PAE) for the ...
Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system. Use of the Prostatype P-score to predict adverse pathology (AP) at radical prostatectomy (RP). This is an ...
ProVerum Limited, a medical device company focused on innovative, safe, and effective solutions for treating benign prostatic hyperplasia (BPH), today announced that Jesse Litwak has joined the ...
Shares of PROCEPT BioRobotics (PRCT) fell 8% on Thursday after Leerink Partnerscdowngraded the stock to Market Perform from Outperform and lowered its price target to $29 from $31, citing growing ...
Your urologist will use several tests to determine how severe your BPH is and whether it affects your bladder health. They may recommend watchful waiting if your BPH is mild. Watchful waiting means ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results